close
This ad will auto close in 10 seconds
GlaxoSmithKline Pharma Q2 net dips 25% at Rs 96 crore

GlaxoSmithKline Pharma Q2 net dips 25% at Rs 96 crore

 GlaxoSmithKline Pharmaceuticals today reported a 25.39 percent dip in standalone net profit at Rs 96.05 crore for the quarter ended September 30.

GSK Pharma completes deal with Novartis Healthcare

GSK Pharma completes deal with Novartis Healthcare

The company has completed its transaction with Novartis Healthcare Pvt Ltd Wednesday whereby it has acquired Novartis' vaccines business and divested its marketed oncology portfolio to Novartis India, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.

GSK Pharma's Bengaluru facility to be operational by 2017

GlaxoSmithKline Pharmaceuticals (GSK India) has said its greenfield manufacturing facility at Bengaluru, having an installed capacity of over 9 billion tablets and capsules per year, will be operational by 2017.

GlaxoSmithKline appoints Annaswamy Vaidheesh as MD

He would succeed current MD Hasit Joshipura, who is leaving office on August 1, 2015, the company said in a statement.

Glaxo considering all options against CCI order

Slapped with a penalty of nearly Rs 61 crore by competition watchdog CCI, GlaxoSmithKline Pharmaceuticals Monday said it would review the order and consider all options, including filing an appeal.

GSK Pharma profit up 6.53% at Rs 102.85 cr in Jan-Mar quarter

GlaxoSmithKline Pharmaceuticals Monday reported 6.53 percent increase in standalone net profit at Rs 102.85 crore for the quarter ended March 31, 2015.

GSK Pharma to transfer cancer drug portfolio to Novartis arm

GlaxoSmithKline Pharmaceuticals board on Thursday approved transfer of its cancer drugs portfolio to an arm of Novartis in India in return for acquiring vaccines portfolio as part of a global deal between the two-multinational pharma giants struck last year.

GSK pays $1 billion to lift Indian unit stake to 75%

GlaxoSmithKline said on Monday it had paid 64 billion rupees to increase its stake in its Indian pharmaceuticals unit to 75 percent, as it banks on rising demand for medicines in emerging markets.

FIPB clears GlaxoSmithKline's Rs 6,400 cr FDI proposal

GlaxoSmithKline Pharmaceuticals is already majority owned and controlled by the GSK Group.

GSK Pharma gains 19% on parent co's move to make open offer

At the NSE, the stock shot-up by 18.90 percent to close the trade at Rs 2,925.

GSK Pharma rallies 20% as parent company launches open offer

Shares of GlaxoSmithkline Pharmaceuticals today skyrocketed by 20 percent after UK-based GlaxoSmithKline Plc announced a voluntary open offer to increase stake in its Indian subsidiary.

GlaxoSmithKline Q3 Net declines 33.73% to Rs 100.95 cr

Drug firm GlaxoSmithKline Pharmaceuticals (GSK) on Monday reported 33.73 percent decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.

GlaxoSmithKline Pharma Q1 net up 37.52% at Rs 169 cr

GlaxoSmithKline Pharmaceuticals Tuesday reported a 37.52 percent rise in its net profit to Rs 169.01 crore for the first quarter ended March 31, 2013 from the same period previous fiscal.

GlaxoSmithKline Pharma Q4 Net inches up 1.29% at Rs 138.51 crore

GlaxoSmithKline Pharmaceuticals on Tuesday reported a 1.29 percent rise in its net profit at Rs 138.51 crore for the quarter ended December 31, 2012.

GlaxoSmithKline Pharma Q3 net up 4.44% at Rs 152.34 crore

GlaxoSmithKline Pharmaceuticals on Friday reported 4.44 percent rise in net profit at Rs 152.34 crore for the quarter ended September 30, 2012 on back of robust sales.